Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2013 Sep 3;139(10):10.1007/s00432-013-1501-6. doi: 10.1007/s00432-013-1501-6

Figure 6. Dot blot analysis of samples with various CA-125 levels.

Figure 6

Dot blot analysis was performed with recombinant autoantigens and serum samples from ovariancancer and non-ovarian cancer patients with various levels of CA-125 (Table 1C).